Skip to content

Clinical trials

Squamous Cell Carcinoma of Head and Neck trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Country / region: Singapore Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20121
20151
20172
20193
20215
20223
20233
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Recruiting6
Terminated6
Completed4
Unknown status4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore5
Novartis Pharmaceuticals5
National Cancer Centre, Singapore3
ALX Oncology Inc.2
Alentis Therapeutics AG2
Bayer2
BeiGene1
Bicara Therapeutics1
Boehringer Ingelheim1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck28
Head and Neck Neoplasms12
Carcinoma, Non-Small-Cell Lung9
Esophageal Squamous Cell Carcinoma5
Colorectal Neoplasms4
Melanoma4
Carcinoma, Renal Cell3
Carcinoma, Ovarian Epithelial2
Carcinoma, Squamous Cell2
Esophageal Neoplasms2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.